Quirk Jeanne
Known title: DirectorCIK: 0001908822
Associated companies
Transaction History
| ACLS | ▼ Sell | Open Market | 1,789 | $251K | 5/19/2026 | View on chart |
| ACLS | ▲ Buy | Grant | 1,440 | $0 | 5/15/2026 | View on chart |
| ACLS | ▲ Buy | Grant | 3,586 | $0 | 5/15/2025 | View on chart |
| ACLS | ▲ Buy | Grant | 1,162 | $0 | 5/15/2024 | View on chart |
| ACLS | ▼ Sell | Open Market | 900 | $160K | 6/12/2023 | View on chart |
| ACLS | ▲ Buy | Grant | 1,282 | $0 | 5/15/2023 | View on chart |
| ACLS | ▲ Buy | Grant | 2,689 | $0 | 5/16/2022 | View on chart |
| ACLS | ▲ Buy | Grant | 2,286 | $0 | 3/15/2022 | View on chart |
| ACLS | ▲ Buy | Grant | 1,143 | $0 | 3/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Axcelis Reports Q2 2026 Results; Shares Slide as Market Rises
Axcelis Technologies released its Q2 2026 earnings and held a call that is now available as a transcript. The shares fell a few points after the market moved higher. The drop comes while the stock is near a support level that has been touched ten times. Analysts have a target range of $140 to $198, with an average of $161.
Axcelis Reports Q2 2026 Results; Shares Slide as Market Rises. Axcelis Technologies released its Q2 2026 earnings and held a call that is now available as a transcript. The shares fell a few points after the market moved higher. The drop comes while the stock is near a support level that has been touched ten times. Analysts have a target range of $140 to $198, with an average of $161.